Ackman Defends JCPenney's (JCP) Strategy, 'Very Comfortable' with Johnson Handling Marketing
Tweet Send to a Friend
Get Alerts JCP Hot Sheet
Price: $17.60 +1.27%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 2.3%
EPS Growth %: -424.0%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 2.3%
EPS Growth %: -424.0%
Trade JCP Now!
Bloomberg reporting Bill Ackman of Pershing Square Capital made some comments related to JCPenney (NYSE: JCP) following news the company's Chief Merchandising Officer Francis has left the company. The comments come from a telephone interview.
Ackman admitted the retailers marketing strategy "wasn't working," but said he believes 100 percent in JCPenney's strategy. Ackman said he is "very comfortable" with Ron Johnson handling the marketing. The money manager believes recent advertisements did not reach the company's core customer.
Shares of JCPenney have tumbled nearly 10 percent Tuesday morning following the exec departure. The stock last traded at $21.94 and does not seem to bouncing following Ackman's reassuring comments.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Ackman admitted the retailers marketing strategy "wasn't working," but said he believes 100 percent in JCPenney's strategy. Ackman said he is "very comfortable" with Ron Johnson handling the marketing. The money manager believes recent advertisements did not reach the company's core customer.
Shares of JCPenney have tumbled nearly 10 percent Tuesday morning following the exec departure. The stock last traded at $21.94 and does not seem to bouncing following Ackman's reassuring comments.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- 'Now You See Me'; JCPenney (JCP) to Tighten-Up Employee Dress Code in Sales-Boost Effort
- Baker Bros. Raises Stake in Vanda Pharma (VNDA) to 13.99%
- Merck (MRK) to Further Streamline R&D Unit; Job Cuts Planned
Create E-mail Alert Related Categories
Hedge Funds, Insiders' BlogRelated Entities
William Ackman, Pershing Square Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
